Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many claims under the Vaccine Damage Payments Scheme have been received between October 2021 and September 2023; how many of these claims relate to vaccines for (a) Covid-19 and (b) other illnesses; and how many claims are still awaiting a final decision per vaccine.

From 1 October 2021 to 1 September 2023, the NHS Business Services Authority has received 6,809 claims relating to COVID-19 vaccinations, and 251 claims relating to vaccines for other illnesses.

Of these claims, 3,933 are currently awaiting a final decision; of which, 3,796 are related to vaccines for COVID-19 and 137 are related to vaccines for other illnesses. These 137 are broken down per vaccine as follows:

- 35 are adult flu

- 33 are unidentified/unclear due to multiple types of vaccinations

- 17 are diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (DTaP/IPV/Hib)

- 15 are measles, mumps and rubella (MMR)

- 9 are human papillomavirus (HPV)

The following vaccines have received fewer than five claims and the exact amount cannot be disclosed as this information may make individuals personally identifiable in the public domain:

- Influenza

- Swine flu (Pandemic influenza A (H1N1) 2009)

- Polio (Poliomyelitis - orally administered)

- Unidentified/unclear

- Haemophilus influenzae type b, meningococcal group C (Hib/Men C)

- Haemophilus influenzae type b (Hib)

- Meningococcal group C (Men C, Men ACWY)

- Pneumococcal (PCV)

- Tuberculosis (TB)

- Tetanus

- Mumps

- Meningococcal group B (Men B)

- Diphtheria, tetanus, pertussis and polio (DTaP/IPV)

- Rubella (German measles)